Maintenance treatment of symptoms (GERD maintenance)
For stomach ulcers (peptic ulcers)
For duodenal ulcers
For ulcers caused byH. Pyloriinfection and to prevent recurrence
For more information on other medications used to treatH. pylori, read the prospectus for each one.
Zollinger-Ellison syndrome where excessive acid is produced in the stomach
Use in children.
This medication should not be administered to children.
Patients with liver problems.
Consult your doctor, who will have special care in the initiation and during treatment with Rabeprazol Combix.
If you take more Rabeprazol Combix than you should
If you take more Rabeprazol Combix than you should, talk to your doctor or go to the hospital immediately. Bring the medication with you.
In case of overdose or accidental ingestion, consult the Toxicological Information Service (Telephone: 91 5620420)
If you forget to take Rabeprazol Combix
Interrupting treatment with Rabeprazol Combix
Relief of symptoms usually occurs before the ulcer has completely healed.
It is essential not to interrupt treatment until your doctor tells you to.
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medicines, Rabeprazol Combix may cause side effects, although
not everyone will experience them.
Side effects are usually mild and improve without you stopping treatment.
Stop taking Rabeprazol Combix and see your doctor immediately if you notice any of the following side effects – you may need urgent medical treatment:
These side effects are very rare (affect less than 1 in 10,000 people).
Other possible side effects;
Frequent (affect less than 1 in 10 people)
Occasional (affect less than 1 in 100 people)
Rare (affect less than 1 in 1,000 people)
Other possible side effects (frequency unknown)
Do not worry about the list of side effects. You may not experience any of them.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
Do not store at a temperature above 25°C.
Store in the outer packaging to protect it from humidity.
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Rabeprazol Combix 10 mg
The active ingredient is rabeprazole sodium. Each tablet contains 10 mg of rabeprazole sodium (equivalent to 9.42 mg of rabeprazole).
The other components are:core: povidone, mannitol (E421), light magnesium oxide, low-substitution hydroxypropyl cellulose, magnesium stearate;coating: ethyl cellulose, light magnesium oxide;enteric coating: methacrylic acid-acrylate copolymer, polysorbate 80, sodium lauryl sulfate, propylene glycol, talc, iron oxide red (E172), iron oxide yellow (E172), titanium dioxide (E171).
Appearance of the product and content of the packaging
Rabeprazol Combix 10 mg is presented as pink enteric-coated (gastrorresistant) tablets in packaging containing aluminum blisters with the tablets housed in individual unit cells.
Rabeprazol Combix tablets are available in blisters containing 28 tablets.
Marketing authorization holder
Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Balkanpharma Dupnitsa Ad
3 Samokovsko Shosse Str.
Dupnitsa
Bulgaria
Last review date of this leaflet: October 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.